Understanding how the IL-21/IL-21R signaling pathway contributes to the host immunity in the colon will further provide insights into the development of novel preventive and therapeutic targets for human subjects with enteric microbial infections and other inflammatory conditions, including inflammatory bowel disease (IBD) and celiac disease. This evidence concerns the gene IL21 and inflammatory bowel disease.